Loading…

CHADS 2 and CHA 2 DS 2 Vasc-Score in Peripheral Systemic Embolism

We analysed the characteristics of patients with an acute peripheral embolic event considering the possible use of the CHADS2-Score and the CHA DS Vasc-Score We retrospectively analyzed 163 cases of acute peripheral arterial embolism treated in the Department of Vascular Medicine of the HELIOS Klini...

Full description

Saved in:
Bibliographic Details
Published in:Journal of atrial fibrillation 2013-06, Vol.6 (1), p.715
Main Authors: Santosa, Frans, Nowak, Thomas, Moysidis, Theodoros, Eickmeier, Frank, Stallinger, Christoph, Luther, Bernd, Knut, Kröger
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We analysed the characteristics of patients with an acute peripheral embolic event considering the possible use of the CHADS2-Score and the CHA DS Vasc-Score We retrospectively analyzed 163 cases of acute peripheral arterial embolism treated in the Department of Vascular Medicine of the HELIOS Klinik Krefeld, Germany, from 2008 to 2011. We retrospectively screened the medical form for information regarding atrail fibrillation (AF) and the risk factors necessary to calculate the CHADS and CHA DS vasc score. Arterial hypertension and age > 75 years were the most frequent risk factors. Mean CHADS score was similar in males and females (2.3 ± 1.5 and 2.3 ± 1.4). 66% of the males and 63.3% of the females scored 2 and more points. Mean CHA DS Vasc score was 3.6 ± 2.0 in males and 4.6 ± 1.9 in females. 85.2% of the males and 95.4% of the females scored more than 2 points. In the medical forms AF was documented in 79 (48%) patients, of which 23 (43 %) were males and 56 (51%) females. Mean CHADS score and mean CHA DS Vasc score were slightly higher in those with AF compared to the total group, but not significantly different. The rate of patients with 2 and more points increased for both scores: CHADS score: males 82.6% and females 76.8%, CHA DS Vasc: males 100% and females 98.2%. Almost half of the patients with AF had had anticoagulation with phenprocoumon before (males 12 (52%), females 24 (43%), but only every 10th was within the therapeutic range (INR ≥2) The number of those with AF is high amongst patients with acute peripheral embolism. According to the CHADS and CHA DS Vasc score, most of these patients had an indication for oral anticoagulation independent form the embolic event.
ISSN:1941-6911
1941-6911